Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $6.9800 (-4.19%) ($6.9800 - $6.9800) on Fri. Aug. 19, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.15% (three month average) | RSI | 69 | Latest Price | $6.9800(-4.19%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX declines -3.3% a day on average for past five trading days. | Weekly Trend | TGTX advances 10.5% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) ICLN(94%) XLK(94%) XBI(90%) SPY(89%) XLC(89%) | Factors Impacting TGTX price | TGTX will decline at least -3.575% in a week (0% probabilities). USO(-23%) TBT(-35%) XOP(5%) XLE(8%) OIH(14%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.575% (StdDev 7.15%) | Hourly BBV | -1.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $7.58(-7.92%) | 10 Day Moving Average | $7.65(-8.76%) | 20 Day Moving Average | $6.95(0.43%) | To recent high | -17.1% | To recent low | 86.9% | Market Cap | $884m | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |